Skip to main navigation Skip to search Skip to main content

Recombinant Bacillus subtilis spores expressing MPT64 evaluated as a vaccine against tuberculosis in the murine model

  • Laura Sibley
  • , Rajko Reljic
  • , David S Radford
  • , Jen-Min Huang
  • , Huynh A Hong
  • , Rocky M Cranenburgh
  • , Simon M Cutting

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article number358
Pages (from-to)170-9
Number of pages10
JournalFEMS Microbiology Letters
Volume358
Issue number2
DOIs
Publication statusPublished - 1 Sept 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Animals
  • Antigens, Bacterial
  • Bacillus subtilis
  • Bacterial Load
  • Bacterial Proteins
  • Cell Surface Display Techniques
  • Cytokines
  • Disease Models, Animal
  • Drug Carriers
  • Enzyme-Linked Immunospot Assay
  • Female
  • Genetic Vectors
  • Lung
  • Mice
  • Mice, Inbred C57BL
  • Recombinant Fusion Proteins
  • Spores, Bacterial
  • T-Lymphocytes
  • Tuberculosis
  • Tuberculosis Vaccines
  • Vaccination
  • Vaccines, Inactivated
  • Vaccines, Synthetic

Cite this